Pura Vida Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Pura Vida Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,900	Closed	-$1.47M	–	201
2022 Q4	$1.47M	Hold	12,900	–	–	0.08%	135
2022 Q3	$798K	Hold	12,900	–	–	0.05%	164
2022 Q2	$1.03M	Buy	+12,900	New	+$1.22M	0.06%	167
2021 Q1	–	Sell	-40,000	Closed	-$2.93M	–	284
2020 Q4	$2.93M	Sell	40,000 -50,000	-56%	-$3.72M	0.11%	128
2020 Q3	$6.99M	Buy	+90,000	New	+$6.19M	0.36%	56
2020 Q2	–	Sell	-32,816	Closed	-$972K	–	150
2020 Q1	$972K	Buy	+32,816	New	+$1.11M	0.12%	75
2017 Q3	–	Sell	-150,000	Closed	-$1.78M	–	105
2017 Q2	$1.78M	Buy	+150,000	New	+$1.87M	0.71%	42
2016 Q4	–	Sell	-151,250	Closed	-$2.74M	–	109
2016 Q3	$2.74M	Buy	+151,250	New	+$2.96M	0.83%	51

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pura Vida Investments's HZNP Position: Q1 2023 in Review

Pura Vida Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 12,900 shares — an estimated $1.47M sold.

Pura Vida Investments first reported a position in HZNP in Q3 2016 and held it in 8 quarters. The position peaked at $6.99M in Q3 2020. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Pura Vida Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Pura Vida Investments sold 12,900 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $1.47M.
Pura Vida Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2016 and held it in 8 quarters.
Pura Vida Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.99M in Q3 2020.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.